News
First iadademstat clinical trial in non-malignant hematological indications MADRID and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, Ticker: ORY), ...
For decades, dentists and scientists have dreamed of helping people regrow lost teeth. Now, thanks to remarkable advances in ...
The FIM Land Speed World Records are scheduled to run from August 23-28 at Utah’s Bonneville Salt Flats.
Now, it’s worth noting Stock Advisor’s total average return is 1,057% — a market-crushing outperformance compared to 185 % ...
20h
TipRanks on MSNAbbVie’s New Phase 2 Trial: A Potential Game-Changer in Cancer Treatment?
Abbvie (($ABBV)) announced an update on their ongoing clinical study. Study Overview: AbbVie is spearheading a Phase 2 ...
Supplements of turmeric, or its active component curcumin, may help people with prediabetes or type 2 diabetes lose weight, ...
Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.
Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...
Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc., in collaboration with Asher ...
In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results